GXO vs DOCS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 19, 2026

GXO

56.5
AI Score
VS
GXO Wins

DOCS

34.6
AI Score

Investment Advisor Scores

GXO

57score
Recommendation
HOLD

DOCS

35score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric GXO DOCS Winner
Revenue 6.74B 156.62M GXO
Net Income 29.00M 24.32M GXO
Net Margin 0.4% 15.5% DOCS
Operating Income 116.00M 33.64M GXO
ROE 1.0% 2.7% DOCS
ROA 0.2% 2.2% DOCS
Total Assets 12.37B 1.08B GXO
Cash 769.00M 273.60M GXO
Current Ratio 0.79 6.08 DOCS
Free Cash Flow -23.00M 41.92M DOCS

Relative Price Performance (Last 90 Days)

GXO 1M: -12.1% · 3M: -2.4% DOCS 1M: +25.0% · 3M: +28.0%

Current Technical Phase

GXO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.3%), weak momentum, RSI 41

RSI (14): 40.8 · Price: $46.35

DOCS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.1% over 20 days), RSI 58

RSI (14): 58.2 · Price: $25.53

Fundamentals Snapshot

Metric GXO DOCS
Market Cap
Forward P/E 12.9 15.6
Trailing P/E 40.9 30.5
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% 0.9%
Operating Margin 0.0% 0.2%
EPS 1.11 0.85
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, GXO is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.